AACR 2017: one presentation and two highly-cited publications

Date Posted: 
2017-04-03

Research excellence at the Vancouver Prostate Centre was demonstrated at the American Association for Cancer Research (AACR) annual meeting, April 1 - 5, 2017.

Dr. Alastair Davies & Dr. Amina Zoubeidi present their work in the Tumor Stem Cell Biology session (April 4, 2017), in a talk titled "EZH2 reprogramming confers intrinsic stem cell properties and developmental plasticity driving neuroendocrine prostate cancer".

Groundbreaking publications led by Dr. Chi and Dr. Gleave were recognized in "The Best of the AACR Journals,” which is a collection of the most-cited articles published in 2015 across the AACR journal portfolio based on the total number of citations from date of publication through January 2017.

The publications are:

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer” Azad et. al., Clinical Cancer Research, 2015 May 15;21(10):2315-24.

Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer" Toren et. al., Molecular Cancer Therapeutics, 2015 Jan;14(1):59-69.
 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.